Filter Releases
 
Press Releases
Date Title and Summary View
Aug 28, 2014
WALTHAM, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reports that the positron emission tomography (PET) imaging from the R...
Aug 19, 2014
CAMBRIDGE, Mass., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that it will present new data from multiple studies of abaloparatide in women with postmenopausal osteoporosis at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, which takes place September 12-15, 2014 in Houston, Te...
Aug 12, 2014
WALTHAM, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reported its financial results for the second quarter ended June 30, 2...
Aug 7, 2014
CAMBRIDGE, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that its President and CEO, Robert Ward, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 10:30 a.m. Eastern Time at the Intercontinental Hotel in Boston. The presentation will be webcast live on the...
Aug 6, 2014
CAMBRIDGE, Mass., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter 2014 financial results on Tuesday, August 12, 2014. In connection with the earnings release, Radius Health will host a conference call and live audio webcast at 8.30 a.m. ET on Tuesday, August 12, 2014 to discus...
Jun 18, 2014
CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS), will present scientific data from studies conducted with abaloparatide (BA058) at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014) in Chicago, Illinois, June 21-24, 2014. Abstracts related to Radius Health in...
Jun 5, 2014
CAMBRIDGE, Mass., June 5, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") announced today that it has priced its initial public offering of 6,500,000 shares of its common stock at a public offering price of $8.00 per share. In addition, Radius has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of com...
May 5, 2014
CAMBRIDGE, MA--(Marketwired - May 5, 2014) - Radius Health Announces Scientific Presentations at the 40th European Calcified Tissue Society (ECTS) Congress and at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014)Radius Health, Inc. will present scientific data from studies conducte...
Jan 9, 2014
CAMBRIDGE, MA--(Marketwired - Jan 9, 2014) - Radius Health, Inc. ("Radius") announced today that it has strengthened its management team with the addition of John Yates, M.D., as Chief Medical Officer and Greg Williams, Ph.D., as Chief Development Officer, and the promotion of Gary Hattersley, Ph.D., to Chief Scientific Officer. ...
Jan 9, 2014
CAMBRIDGE, MA--(Marketwired - Jan 9, 2014) - Radius Health, Inc. ("Radius"), a late-stage biopharmaceutical company focused on developing novel therapeutics for osteoporosis and other serious endocrine-mediated diseases, today announced topline results from a Phase 2 study of BA058, or abaloparatide1, the company's novel synthetic pepti...
Dec 17, 2013
CAMBRIDGE, MA--(Marketwired - Dec 17, 2013) - Radius Health, Inc. ("Radius") announced today the appointment of Robert Ward as President and Chief Executive Officer. Mr. Ward takes on the role of CEO at a dynamic time when Radius is advancing its osteoporosis program in late-stage human clinical trials: The lead program, BA058-SC -- a potential...
Apr 25, 2013
CAMBRIDGE, MA--(Marketwired - Apr 25, 2013) -   Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health co...
Apr 18, 2013
CAMBRIDGE, MA--(Marketwired - Apr 18, 2013) -    Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's hea...
Mar 12, 2013
CAMBRIDGE, MA--(Marketwire - Mar 12, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the ...
Feb 26, 2013
CAMBRIDGE, MA--(Marketwire - Feb 26, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, announced today that it will present at the 33rd annual Cowen & Company Health Care Conference. Michael Wyzga, Presi...
= add release to Briefcase